Table 1.  Characteristics of Included Patients
   IPA (n = 9)  Non-IPA (n = 33)  All Patients (N = 42)
Age, yr, mean (range)  68 (39–76)  60 (25–79)  62 (25–79)
Sex, M, n (%)  5 (55.6%)  28 (84.8%)  33 (78.6%)
BMI, kg/m2  30 [26–34]  27 [27–29]  29 [28–30]
APACHE IV pred mort  19% [12–25]*  21% [17–26]  21% [17–25]
Lowest PF ratio  94 [74–114]  102 [91–114]  100 [91.2–110.2]
Galactomannan in BAL, ODI  3.33 [2.67–4.00]*  0.21 [0.17–0.27]  0.67 [0.39–0.95]
COPD, n (%)  4 (44.4%)*  4 (12.1%)  8 (19.0%)
DM, n (%)  1 (11.1%)  9 (27.3%)  10 (23.8%)
Chronic corticosteroid use, n (%)  1 (11.1%)  0  1 (2.4%)
Neutropenia, n  0  0  0
Stem cell transplant, n  0  0  0
Immunodeficiency (acquired/inherited), n (%)  1 (11.1%)  0  1 (2.4%)
Arterial hypertension, n (%)  3 (33.3%)  10 (30.3%)  13 (30.9%)
ICU LOS, d  37 [26–47]*  19 [15–23]  23 [18–27]
ICU mortality, n (%)  2 (22.2%)  5 (15.1%)  7 (16.6%)
Definition of abbreviations: APACHE IV = Acute Physiology and Chronic Health Evaluation IV; BMI = body mass index; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; IPA = invasive pulmonary aspergillosis; LOS = length of stay; ODI = optical density index; PF = PaO2/FiO2; pred mort = predicted mortality.
Data are expressed as mean [95% confidence interval] unless stated otherwise.
*  P < 0.05.